Attributes | Values |
---|
rdf:type
| |
Description
| - Aims: Continuous glucose monitoring (CGM) using transcutaneous sensors is becoming a sophisticated method to control and regulate glucose metabolism. The trancutaneous sensor of the CGM system (CGMS Medtronic Minimed, Northridge, CA, USA) is chosen to measure glucose concentration in interstitial fluid up to three days after insertion even though is function remains stable for a longer period. The question arises, which factors really limit the period of sensor insertion without unnecessary risk. The aim of this study was to assess any adverse events occurring in the course of 9 days after the sensor insertion.
- Aims: Continuous glucose monitoring (CGM) using transcutaneous sensors is becoming a sophisticated method to control and regulate glucose metabolism. The trancutaneous sensor of the CGM system (CGMS Medtronic Minimed, Northridge, CA, USA) is chosen to measure glucose concentration in interstitial fluid up to three days after insertion even though is function remains stable for a longer period. The question arises, which factors really limit the period of sensor insertion without unnecessary risk. The aim of this study was to assess any adverse events occurring in the course of 9 days after the sensor insertion. (en)
- Cíle: kontinuální monitorování glukózy (CGM) při použití transkutálních senzorů je vhodnou metodou kontroly a regulace glukózového metabolismu. Transkutální senzor CGM (CGMS Medtronic Minimed, Northridge, CA, USA) byl zvolen k měření koncentrace glukózy v intersticiální tekutině po dobu 3 dnů od zavedení. Jeho funkce zůstává stabilní i po delší dobu aplikace. Je otázkou, které faktory limitují dobu inserce senzoru bez možného rizika. Cílem této studie je stanovení možných nepříznivých jevů v průběhu 9 dnů po aplikaci senzoru. (cs)
|
Title
| - Occurence of adverse events due to continuous glucose monitoring
- Výskyt nepříznivých komplikací kontinuálního monitoringu glykemie (cs)
- Occurence of adverse events due to continuous glucose monitoring (en)
|
skos:prefLabel
| - Occurence of adverse events due to continuous glucose monitoring
- Výskyt nepříznivých komplikací kontinuálního monitoringu glykemie (cs)
- Occurence of adverse events due to continuous glucose monitoring (en)
|
skos:notation
| - RIV/61989592:15110/07:00004263!RIV08-MSM-15110___
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15110/07:00004263
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Continuous glucose monitoring; Sensors; Adverse events (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Luža, Jiří
- Kuzmina, Galina
- Fajkusová, Zuzana
- Jadviščoková, Tereza
- Pallayová, Mária
|
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |
is http://linked.open...avai/riv/vysledek
of | |